美國輸液藥物市場規模、佔有率、趨勢分析報告：按類型、營養和細分市場預測，2024-2030 年

美國輸液藥物市場成長與趨勢：

根據Grand View Research, Inc.最新報告顯示，到2030年，美國靜脈輸液市場規模預計將達79億美元，2024年至2030年複合年成長率為7.8%。

由於疾病盛行率上升和手術數量增加，市場出現成長。此外，不斷增加的老年人口更容易罹患癌症、神經病變、心血管疾病和脊椎損傷等非傳染性疾病，可能會影響市場成長。

越來越多的醫院、門診手術中心、輸液中心、醫療水療中心等正在促進市場成長。根據門診手術中心協會公佈的資料，2022年美國共有6,087個門診手術中心，其中加州最多（848個），其次是佛羅裡達州（468個）。

靜脈補水療法是治療嚴重脫水的一種非常有效的治療方法。患有某些慢性疾病（例如糖尿病和某些腎臟疾病）的人可能面臨更高的脫水風險。水合療法有助於恢復體內適當的電解質平衡。最常用的靜脈注射治療是含有水和氯化鈉的簡單生理食鹽水。然而，也經常使用含有糖（例如葡萄糖、右旋糖和左旋糖）的溶液。例如，領先的輸液治療和輸液技術公司 Baxter 與西北醫學院合作，於 2023 年 12 月完成了靜脈注射袋回收試驗計畫的初始階段。這項舉措從垃圾掩埋場轉移了超過 6 噸 PVC IV 袋廢棄物。如果端到端鋪設，這個數量可以覆蓋整個芝加哥，從而促進環境上永續的再利用。

美國靜脈注射市場報告亮點

• 按類型分類，由於慢性病的增加及其治療需要手術，綜合腸外營養細分市場在 2023 年以 67.02% 的最大銷售佔有率引領市場。
• 從營養成分來看，維生素和礦物質（鹽和電解質）領域預計在預測期內將以 10.0% 的複合年成長率成長最快。
• 從營養成分來看，單劑量胺基酸細分市場處於領先地位，2023 年銷售佔有率最大，為 31.27%。
• 2020 年 9 月，百特獲得美國FDA核准，開發其產品 Clinimix 的新配方，以更少的葡萄糖提供更多的蛋白質。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章美國輸液藥物市場變數、趨勢與範圍

• 市場體系展望
  • 母市場展望
  • 相關/附隨市場展望
• 市場動態
  • 市場推動要素分析
  • 市場限制因素分析
• 美國輸液藥物市場分析工具
  • 產業分析-波特五力分析
  • PESTEL分析

第4章美國輸液藥品市場：類型估計與趨勢分析

• 2023年及2030年產品市場佔有率
• 細分儀表板
• 美國輸液藥物市場：按類型分類的前景
• 2018-2030年市場規模、預測及趨勢分析
• 高熱量輸液
• 週邊腸外營養

第5章美國輸液藥品市場：營養估算及趨勢分析

• 2023年及2030年營養品市場佔有率
• 細分儀表板
• 美國輸液市場：美國營養品展望
• 2018-2030年市場規模、預測及趨勢分析
• 碳水化合物
• 單劑量胺基酸
• 維生素和礦物質
• 腸外脂肪乳
• 其他

第6章 競爭狀況

• 主要市場參與企業的最新趨勢和影響分析
• 公司/競爭對手分類
• 供應商情況
• 公司簡介
  • Fresenius Kabi AG
  • Pfizer Inc.
  • Baxter
  • ICU Medical
  • Option Care Health Inc.
  • B. Braun Medical Inc

U.S. Intravenous Solutions Market Growth & Trends:

The U.S. intravenous solutions market size is anticipated to reach USD 7.90 billion by 2030 and is projected to grow at a CAGR of 7.8% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market growth is observed due to the rising prevalence of diseases, and the increasing number of surgeries. In addition, the rising number of geriatric population susceptible to non-communicable diseases such as cancer, neurological disorders, cardiovascular disorders, and spinal injuries is likely to impact market growth.

The increasing number of hospitals, ambulatory surgical centers, intravenous (IV) solutions infusion centers, and med spas contribute to the market growth. According to the data published by the Ambulatory Surgery Center Association, the number of ambulatory surgery centers in the U.S. in 2022 was 6087, out of which California state had the highest number (848), followed by Florida state (468).

IV hydration therapy is a highly effective treatment for severe dehydration. Individuals with certain chronic illnesses, such as diabetes or certain kidney conditions, may be at a greater risk of dehydration. Rehydration therapy helps to restore the proper electrolyte balance in the body. The most commonly used IV treatment is a simple saline solution that contains water and sodium chloride. However, solutions containing sugar, such as glucose, dextrose, or levulose, are also frequently used. For instance, in December 2023, Baxter, a prominent figure in infusion therapies and technologies, completed the initial phase of its pilot program for IV bag recycling with Northwestern Medicine. This effort has diverted over six tons of PVC IV bag waste from landfills. This amount could stretch across Chicago if laid end-to-end, promoting environmentally sustainable reuse.

U.S. Intravenous Solutions Market Report Highlights:

• Based on type, the total parenteral nutrition segment led the market with the largest revenue share of 67.02% in 2023, owing to the increased number of chronic disorders and the surgeries need to treat them
• Based on nutrients, the vitamins and minerals (salt and electrolyte) segment is expected to grow at the fastest CAGR of 10.0% over the forecast period
• Based on nutrients, The single dose amino acids segment led the market with the largest revenue share 31.27% in 2023
• In September 2020, Baxter got the U.S. FDA approval to develop new formulations of its product Clinimix to provide more protein while delivering less dextrose

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Type
  • 1.2.2. Nutrients
  • 1.2.3. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Volume price analysis (Model 2)
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Type outlook
  • 2.2.2. Nutrients outlook
• 2.3. Competitive Insights

Chapter 3. U.S. Intravenous Solutions Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
  • 3.2.2. Market restraint analysis
• 3.3. U.S. Intravenous Solutions Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. U.S. Intravenous Solutions Market: Type Estimates & Trend Analysis

• 4.1. Product Market Share, 2023 & 2030
• 4.2. Segment Dashboard
• 4.3. U.S. Intravenous Solutions Market by Type Outlook
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.4.1. Total Parenteral Nutrition (TPN)
    • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
  • 4.4.2. Peripheral Parenteral Nutrition (PPN)
    • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 5. U.S. Intravenous Solutions Market: Nutrients Estimates & Trend Analysis

• 5.1. Nutrients Market Share, 2023 & 2030
• 5.2. Segment Dashboard
• 5.3. U.S. Intravenous Solutions Market by Nutrients Outlook
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.4.1. Carbohydrates
    • 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
  • 5.4.2. Single dose amino acids
    • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
  • 5.4.3. Vitamins and minerals
    • 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
  • 5.4.4. Parenteral lipid emulsion
    • 5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
  • 5.4.5. Others
    • 5.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 6. Competitive Landscape

• 6.1. Recent Developments & Impact Analysis, By Key Market Participants
• 6.2. Company/Competition Categorization
• 6.3. Vendor Landscape
  • 6.3.1. List of key distributors and channel partners
  • 6.3.2. Key customers
  • 6.3.3. Key company heat map analysis, 2023
• 6.4. Company Profiles
  • 6.4.1. Fresenius Kabi AG
    • 6.4.1.1. Company overview
    • 6.4.1.2. Financial performance
    • 6.4.1.3. Product benchmarking
    • 6.4.1.4. Strategic initiatives
  • 6.4.2. Pfizer Inc.
    • 6.4.2.1. Company overview
    • 6.4.2.2. Financial performance
    • 6.4.2.3. Product benchmarking
    • 6.4.2.4. Strategic initiatives
  • 6.4.3. Baxter
    • 6.4.3.1. Company overview
    • 6.4.3.2. Financial performance
    • 6.4.3.3. Product benchmarking
    • 6.4.3.4. Strategic initiatives
  • 6.4.4. ICU Medical
    • 6.4.4.1. Company overview
    • 6.4.4.2. Financial performance
    • 6.4.4.3. Product benchmarking
    • 6.4.4.4. Strategic initiatives
  • 6.4.5. Option Care Health Inc.
    • 6.4.5.1. Company overview
    • 6.4.5.2. Financial performance
    • 6.4.5.3. Product benchmarking
    • 6.4.5.4. Strategic initiatives
  • 6.4.6. B. Braun Medical Inc
    • 6.4.6.1. Company overview
    • 6.4.6.2. Financial performance
    • 6.4.6.3. Product benchmarking
    • 6.4.6.4. Strategic initiatives

List of Tables

• Table 1. List of abbreviations
• Table 2. U.S. Intravenous solutions market, by type, 2018 - 2030 (USD Billion)
• Table 3. U.S. Intravenous solutions market, by type, 2018 - 2030 (Thousand Units)
• Table 4. U.S. Intravenous solutions market, by nutrients, 2018 - 2030 (USD Billion)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Market research approaches
• Fig. 5 Value-chain-based sizing & forecasting
• Fig. 6 QFD modeling for market share assessment
• Fig. 7 Market formulation & validation
• Fig. 8 U.S. intravenous solutions market: market outlook
• Fig. 9 U.S. intravenous solutions competitive insights
• Fig. 10 Parent market outlook
• Fig. 11 Related/ancillary market outlook
• Fig. 12 Penetration and growth prospect mapping
• Fig. 13 U.S. intravenous solutions market driver impact
• Fig. 14 U.S. intravenous solutions market restraint impact
• Fig. 15 U.S. intravenous solutions: Type movement analysis
• Fig. 16 U.S. intravenous solutions: Type outlook and key takeaways
• Fig. 17 Total parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Billion)
• Fig. 18 Peripheral parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Billion)
• Fig. 19 U.S. intravenous solutions: Nutrients movement analysis
• Fig. 20 U.S. intravenous solutions: Nutrients outlook and key takeaways
• Fig. 21 Carbohydrates market estimates and forecasts, 2018 - 2030 (USD Billion)
• Fig. 22 Single dose amino acids market estimates and forecasts, 2018 - 2030 (USD Billion)
• Fig. 23 Vitamins and minerals market estimates and forecasts, 2018 - 2030 (USD Billion)
• Fig. 24 Parenteral lipid emulsion market estimates and forecasts, 2018 - 2030 (USD Billion)
• Fig. 25 Others market estimates and forecasts, 2018 - 2030 (USD Billion)